- Home
- DRTS vs CRVO Comparison
DRTS vs CRVO Comparison
Compare DRTS & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRTS
- CRVO
- Stock Information
- Founded
- DRTS 2015
- CRVO 2001
- Country
- DRTS Israel
- CRVO United States
- Employees
- DRTS N/A
- CRVO N/A
- Industry
- DRTS Medical/Dental Instruments
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- DRTS Health Care
- CRVO Health Care
- Exchange
- DRTS Nasdaq
- CRVO Nasdaq
- Market Cap
- DRTS 159.1M
- CRVO 160.4M
- IPO Year
- DRTS N/A
- CRVO N/A
- Fundamental
- Price
- DRTS $2.32
- CRVO $9.60
- Analyst Decision
- DRTS Strong Buy
- CRVO Strong Buy
- Analyst Count
- DRTS 3
- CRVO 6
- Target Price
- DRTS $8.00
- CRVO $53.67
- AVG Volume (30 Days)
- DRTS 25.7K
- CRVO 84.0K
- Earning Date
- DRTS 11-19-2024
- CRVO 11-12-2024
- Dividend Yield
- DRTS N/A
- CRVO N/A
- EPS Growth
- DRTS N/A
- CRVO N/A
- EPS
- DRTS N/A
- CRVO N/A
- Revenue
- DRTS N/A
- CRVO $10,066,550.00
- Revenue This Year
- DRTS N/A
- CRVO $54.67
- Revenue Next Year
- DRTS N/A
- CRVO N/A
- P/E Ratio
- DRTS N/A
- CRVO N/A
- Revenue Growth
- DRTS N/A
- CRVO 116.29
- 52 Week Low
- DRTS $1.75
- CRVO $5.85
- 52 Week High
- DRTS $3.40
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- DRTS 55.81
- CRVO 27.74
- Support Level
- DRTS $2.20
- CRVO $9.31
- Resistance Level
- DRTS $2.30
- CRVO $11.44
- Average True Range (ATR)
- DRTS 0.07
- CRVO 0.89
- MACD
- DRTS 0.01
- CRVO -0.21
- Stochastic Oscillator
- DRTS 100.00
- CRVO 7.37
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.